过去五十年年轻人群中系统性硬化症死亡率持续下降
基于美国全国死亡数据库和人口普查数据,分析1968至2015年系统性硬化症(SSc)按年龄的死亡率变化。≤44岁人群SSc年龄标化死亡率从1968年每百万人1.0降至2015年0.4,累计下降60%;≥65岁人群则累计上升187.0%。
要点
- ≤44岁人群SSc死亡比例年均变化-2.2%,非SSc为-1.5%。
- ≤44岁人群SSc年龄标化死亡率从1968年1.0降至2015年0.4每百万人。
- ≥65岁人群SSc年龄标化死亡率累计上升187.0%,年均变化2.0%。
核心结论
- 过去五十年SSc死亡率在年轻人群中持续下降。
- ≤44岁人群SSc年龄标化死亡率累计下降60%,年均变化-1.9%。
- ≥65岁人群SSc年龄标化死亡率累计上升187.0%,年均变化2.0%。
研究设计与样本
- 基于美国全国死亡数据库和全体美国居民人口普查数据的人群研究。
- 计算1968至2015年每年SSc与非SSc按年龄的死亡比例及年龄标化死亡率(ASMR)。
- 采用joinpoint回归估计各参数的平均年度百分比变化(AAPC)。
主要发现
- 1968至2015年SSc作为根本死因的记录:≤44岁5457例,45-64岁18395例,≥65岁22946例。
- ≤44岁人群年度死亡比例下降幅度SSc大于非SSc:AAPC -2.2%(95%CI -2.4%至-2.0%)vs -1.5%(-1.9%至-1.1%)。
- ≤44岁人群SSc-ASMR从1968年每百万人1.0(95%CI 0.8-1.2)降至2015年0.4(0.3-0.5),累计下降60%,AAPC -1.9%(95%CI -2.5%至-1.2%)。
- ≤44岁人群SSc-ASMR与非SSc-ASMR比值累计下降20%,AAPC -0.3%(95%CI -1.15%至0.55%)。
- ≥65岁人群SSc-ASMR累计上升187.0%,AAPC 2.0%(95%CI 1.8-2.2);SSc-ASMR与非SSc-ASMR比值累计上升395.4%,AAPC 3.3%(95%CI 2.9-3.7)。
关键数值与推荐
- ≤44岁人群SSc-ASMR的AAPC为-1.9%(95%CI -2.5%至-1.2%)。
- ≥65岁人群SSc-ASMR的AAPC为2.0%(95%CI 1.8-2.2)。
- ≥65岁人群SSc-ASMR与非SSc-ASMR比值的AAPC为3.3%(95%CI 2.9-3.7)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to assess SSc mortality by age in the general population over the past five decades. METHODS: This is a population-based study using a national mortality database and the census data for all US residents. We calculated the proportions of deaths for SSc and for all other causes (non-SSc) by age, and calculated age-standardized mortality rates (ASMRs) for SSc and non-SSc, and the ratio of SSc-ASMR to non-SSc-ASMR by age groups for each year from 1968 through 2015. We performed joinpoint regression to estimate the average annual percent change (AAPC) for each of these parameters. RESULTS: SSc was recorded as the underlying cause of death in 5457 decedents aged ≤44 years, 18 395 aged 45-64, and 22 946 aged ≥65 from 1968 through 2015. At ages ≤44, the proportion of annual deaths decreased more for SSc than for non-SSc: AAPC, -2.2% (95% CI, -2.4% to -2.0%) for SSc vs -1.5% (-1.9% to -1.1%) for non-SSc. Consistently, SSc-ASMR decreased from 1.0 (95% CI, 0.8-1.2) in 1968 to 0.4 (0.3-0.5) per million persons in 2015, a cumulative decrease of 60% at an AAPC of -1.9% (95% CI, -2.5% to -1.2%) at ages ≤44. The SSc-ASMR:non-SSc-ASMR ratio also decreased [cumulative -20%; AAPC -0.3% (95% CI, -1.15% to 0.55%)] in the ≤44-years group. In contrast, those aged ≥65 experienced a steep increase in the SSc-ASMR [cumulative 187.0%; AAPC 2.0% (95% CI, 1.8-2.2)] and the SSc-ASMR:non-SSc-ASMR ratio [cumulative 395.4%; AAPC 3.3% (95% CI, 2.9-3.7)]. CONCLUSION: Mortality for SSc has steadily decreased at younger ages over the past five decades.
引用
- Yen EY, Singh DR, Singh RR, et al. Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades. Rheumatology (Oxford). 2024. PMID: 37216898. doi:10.1093/rheumatology/kead233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。